TELO — Telo Genomics Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$12.12m
- CA$10.86m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.07 | -1.24 | -1.07 | -2.11 | -2.82 |
Depreciation | |||||
Non-Cash Items | 0.343 | 0.264 | -0.046 | 0.151 | 0.16 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.32 | -0.206 | -0.051 | 0.107 | -0.002 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -0.328 | -1.12 | -1.1 | -1.79 | -2.63 |
Capital Expenditures | 0 | — | -0.009 | -0.025 | -0.069 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | -0.009 | 0 | — | — |
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | -0.009 | -0.009 | -0.025 | -0.069 |
Financing Cash Flow Items | 0 | -0.106 | -0.149 | -0.017 | -0.207 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.28 | 2.03 | 3.83 | 0.877 | 2.68 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.048 | 0.901 | 2.72 | -0.944 | -0.02 |